56 related articles for article (PubMed ID: 8569597)
1. Targeting of non-small cell lung cancer using HMFG1-99mTc monoclonal antibodies.
Pavlović S; Jovanović D; Radosavljević G; Kozarević N; Nastić-Mirić D; Rebić R; Bosnjáković V; Epenetos A
Med Pregl; 1993; 46 Suppl 1():26-8. PubMed ID: 8569597
[TBL] [Abstract][Full Text] [Related]
2. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA
Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy with a technetium-99m labelled anti-epithelial growth factor receptor antibody in patients with non-small cell lung cancer.
Schillaci O; Danieli R; Picardi V; Bagni O; Di Loreto M; Scopinaro F
Anticancer Res; 2001; 21(5):3571-4. PubMed ID: 11848525
[TBL] [Abstract][Full Text] [Related]
4. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies.
Friedman S; Sullivan K; Salk D; Nelp WB; Griep RJ; Johnson DH; Blend MJ; Aye R; Suppers V; Abrams PG
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1069-78. PubMed ID: 1962776
[TBL] [Abstract][Full Text] [Related]
5. NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer.
Rusch V; Macapinlac H; Heelan R; Kramer E; Larson S; McCormack P; Burt M; Martini N; Ginsberg R
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):200-4. PubMed ID: 8393504
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer 99mTc SM3 radioimmunoscintigraphy.
Granowska M; Biassoni L; Carroll MJ; Howell R; Mather SJ; Ellison D; Granowski A; Britton KE
Acta Oncol; 1996; 35(3):319-21. PubMed ID: 8679263
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
[TBL] [Abstract][Full Text] [Related]
8. Detection of suspected primary lung cancer by scintigraphy with indium-111-anti-carcinoembryonic antigen monoclonal antibodies (type F023C5).
Biggi A; Buccheri G; Ferrigno D; Viglietti A; Farinelli MC; Comino A; Leone A; Quaranta M; Taviani M
J Nucl Med; 1991 Nov; 32(11):2064-8. PubMed ID: 1941139
[TBL] [Abstract][Full Text] [Related]
9. Imaging lung cancer with radiolabeled antibodies.
Breitz HB; Sullivan K; Nelp WB
Semin Nucl Med; 1993 Apr; 23(2):127-32. PubMed ID: 8390098
[TBL] [Abstract][Full Text] [Related]
10. Expression of human milk fat globule antigens HMFG1 and HMFG2 on ovarian tumours and lung tumours.
Hay FG; Leonard RC
Dis Markers; 1988 Mar; 6(1):29-39. PubMed ID: 2456176
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies in the diagnosis and therapy of lung cancer].
Campobasso N; Dammacco F
Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy: Importance for researchers and patients.
Britton KE; Granowska M
Acta Oncol; 1996; 35(3):313-7. PubMed ID: 8679262
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunodetection of lung cancer with IMACIS-1, I-131 labeled monoclonal antibodies to CEA and CA19-9. Comparison of accumulations in irradiated and non-irradiated site.
Kazumoto T; Mitsuhashi N; Hayakawa K; Yonome I; Niibe H
Ann Nucl Med; 1993 Feb; 7(1):39-44. PubMed ID: 8384868
[TBL] [Abstract][Full Text] [Related]
14. The immunodiagnosis of lung cancer with monoclonal antibodies.
Egri G; Takáts A
Med Sci Monit; 2005 Sep; 11(9):RA296-300. PubMed ID: 16127376
[TBL] [Abstract][Full Text] [Related]
15. Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigen.
Dienhart DG; Schmelter RF; Lear JL; Miller GJ; Glenn SD; Bloedow DC; Kasliwal R; Moran P; Seligman P; Murphy JR
Cancer Res; 1990 Nov; 50(21):7068-76. PubMed ID: 2170015
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
[TBL] [Abstract][Full Text] [Related]
18. Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancer.
Simms MS; Murray A; Denton G; Scholfield DP; Price MR; Perkins AC; Bishop MC
Urol Res; 2001 Feb; 29(1):13-9. PubMed ID: 11310209
[TBL] [Abstract][Full Text] [Related]
19. Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancer.
Garkavij M; Samarzija M; Ewers SB; Jakopovic M; Tezak S; Tennvall J
Anticancer Res; 2005; 25(6C):4663-71. PubMed ID: 16334158
[TBL] [Abstract][Full Text] [Related]
20. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
